Related references
Note: Only part of the references are listed.Olverembatinib: First Approval
Sohita Dhillon
DRUGS (2022)
Efficacy and safety of CD19-specific CAR T-cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL
Yuekun Qi et al.
BLOOD (2022)
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al.
BLOOD (2022)
Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions
Maria Thastrup et al.
LEUKEMIA (2022)
Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase
Shyam A. Patel et al.
JCO PRECISION ONCOLOGY (2021)
Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data
Lennart Lenk et al.
CANCER AND METASTASIS REVIEWS (2020)
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
Robin Foa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Successful application of anti-CD19 CAR-T therapy with IL-6 knocking down to patients with central nervous system B-cell acute lymphocytic leukemia
Li-Yun Chen et al.
TRANSLATIONAL ONCOLOGY (2020)
Recent advances in the treatment of acute lymphoblastic leukemia
Hind Rafei et al.
LEUKEMIA & LYMPHOMA (2019)
Managing CNS disease in adults with acute lymphoblastic leukemia
Richard A. Larson
LEUKEMIA & LYMPHOMA (2018)
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Hagop Kantarjian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents
Kyogo Suzuki et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
Zhaohui Gu et al.
NATURE COMMUNICATIONS (2016)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
National Institutes of Health Stroke Scale (NIHSS)
Li Khim Kwah et al.
JOURNAL OF PHYSIOTHERAPY (2014)
Drug transport across the blood-brain barrier
William M. Pardridge
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Tumor regression in cancer patients by very low doses of a T cell-engaging antibody
Ralf Bargou et al.
SCIENCE (2008)
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
Adele K. Fielding et al.
BLOOD (2007)